Synthetic Neoepitopes of the Transglutaminase–Deamidated Gliadin Complex as Biomarkers for Diagnosing and Monitoring Celiac Disease
Authors:
- 1 February 2019
- journal article
- research article
- Published by Elsevier in Gastroenterology
- Vol. 156 (3) , 582-591.e1
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- T Cells in Celiac DiseaseThe Journal of Immunology, 2017
- Amount May Beat Timing: Gluten Intake and Risk of Childhood Celiac DiseaseClinical Gastroenterology and Hepatology, 2016
- Determination of B-Cell Epitopes in Patients with Celiac Disease: Peptide MicroarraysPLOS ONE, 2016
- ACG Clinical Guidelines: Diagnosis and Management of Celiac DiseaseAmerican Journal of Gastroenterology, 2013
- Detection of Celiac Disease and Lymphocytic Enteropathy by Parallel Serology and Histopathology in a Population-Based StudyGastroenterology, 2010
- Celiac Disease Revealed in 3% of Swedish 12‐year‐olds Born During an EpidemicJournal of Pediatric Gastroenterology and Nutrition, 2009
- Celiac DiseaseClinical Chemistry, 2001
- T cells from celiac disease lesions recognize gliadin epitopes deamidated in situ by endogenous tissue transglutaminaseEuropean Journal of Immunology, 2001
- Tissue transglutaminase autoantibody enzyme-linked immunosorbent assay in detecting celiac diseaseGastroenterology, 1998
- Increasing incidence of childhood coeliac disease in Sweden. Results of a national studyActa Paediatrica, 1992